Dysgerminoma of the ovary: review of 27 cases. 1991

S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
Department of Radiation Oncology, Tata Memorial Hospital, Bombay, India.

Twenty-seven patients with pure dysgerminoma were seen at the Tata Memorial Hospital, Bombay, between January 1980 and December 1984. Of the 10 patients in stage I, 2 patients underwent a unilateral salpingoophorectomy (USO) and were kept under observation without any adjuvant therapy, while the remaining patients received adjuvant treatment following surgery. All of the 6 patients in stage II and 4 of 7 in stage III had total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAHBSO) followed by postoperative radiotherapy. One patient presented in stage IV and 3 patients presented with recurrence after previous definitive treatment undertaken at other institutions. The disease free, as well as the overall survival, at 108 months, for the 24 cases primarily treated at this institution, is 81% and 88% respectively, and, for patients in stages I and II, 100% (Kaplan-Meier estimation). The need for controlled clinical trials to devise optimal therapy in the early clinical stages and use of chemotherapy for advanced stages of this highly curable entity are stressed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
November 1984, Ginecologia y obstetricia de Mexico,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
July 1987, Zhonghua zhong liu za zhi [Chinese journal of oncology],
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
January 1969, Akusherstvo i ginekologiia,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
January 2000, European journal of gynaecological oncology,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
January 1985, Zhonghua fu chan ke za zhi,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
July 1950, American journal of obstetrics and gynecology,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
April 1995, Ginekologia polska,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
January 1988, Zentralblatt fur Gynakologie,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
March 1985, Zhonghua fu chan ke za zhi,
S S Susnerwala, and S C Pande, and S K Shrivastava, and K A Dinshaw
December 1957, American journal of surgery,
Copied contents to your clipboard!